Results 251 to 260 of about 332,782 (345)

The power of GM-CSF: immune regulation in the defense against <i>Phialophora verrucosa</i> infection. [PDF]

Front Immunol
Dong Q, Lu J, Liu M, Wu W, Kang Y, Zhang R.   +5 more
europepmc   +1 more source

The 9th Edition of the UICC TNM Classification of Malignant Tumours: Updates and Rationale for Change

International Journal of Cancer, EarlyView.
ABSTRACT The standard for assessing and recording the extent of the tumour, a necessity for most malignancies, is the Tumour Node Metastases (TNM) classification. The Union for International Cancer Control (UICC) TNM committee has defined this since the early 1950s.
James D. Brierley, Liesbet J. Van Eycken, Meredith E. Giuliani, Brian A. Rous, Shao Hui Huang, Hisao Asamura, Mary K. Gospodarowicz, Anne W. Lee, Brian O'Sullivan   +8 more
wiley   +1 more source

GM-CSF Armed Oncolytic Adenovirus Enhances T-Cell Infiltration and Suppresses Local and Distal Tumor Growth. [PDF]

Viruses
Xu HW, Wang QW, Zhao M, Jun J, Shu RG, Shi YS, Peng XL, Yu JM, Zheng YP, Fu YH, He JS.   +10 more
europepmc   +1 more source

A influência da desnutrição proteíca sobre a produção DE GM-CSF E M-CSF por macrófagos peritoneiais

, 2015
Dalila Cunha de Oliveira, Araceli Aparecida Hastreiter, Primavera Borelli, Ricardo Ambrósio Fock   +3 more
openalex   +1 more source

Mutated IL-32θ (A94V) inhibits COX2, GM-CSF and CYP1A1 through AhR/ARNT and MAPKs/NF-κB/AP-1 in keratinocytes exposed to PM10 [PDF]

Jinju Kim, Chae-Min Lim, Nahyun Kim, Hong-Gyum Kim, Jin Tae Hong, Young Yang, Do‐Young Yoon   +6 more
openalex   +1 more source

The Role of GM-CSF in Multiple Sclerosis [PDF]

Drug Research, 2013
openaire   +2 more sources

Tumor‐Regional Immune Microenvironment: A Critical Factor in the Design of Radiotherapy–Immunotherapy Combination Trials

International Journal of Cancer, EarlyView.
ABSTRACT Clinical trials combining radiotherapy (RT) with immune checkpoint blockade (ICB) have shown improved outcomes in only a fraction of patients, and optimal strategies for integrating these modalities remain under intense investigation. With a few exceptions, phase III combination trials have yielded disappointing results.
Xuanwei Zhang, Hui Wang, Weiyan Tang, Kai Kang, Kateryna Onyshchenko, Taotao Huang, Dan Liu, Jianxin Xue, You Lu, Gabriele Niedermann, Ren Luo   +10 more
wiley   +1 more source

Adjunctive GM-CSF therapy enhances host defense against systemic <i>Candida auris</i> infection in immunosuppressed mice. [PDF]

Front Immunol
Mattos EC, Das Gupta K, Quintanilla D, Hautau H, Ibrahim AS, Singh S.   +5 more
europepmc   +1 more source

Clinical Implementation and Oncological Relevance of Molecular Profiling in Brain Metastases Patients—A Multicenter Retrospective Cohort Study

International Journal of Cancer, EarlyView.
While current guidelines recommend the analysis of established cancer driver genes in brain metastases, little is known about its real‐life implementation. This multicenter study revealed an upward trend in the profiling rates of surgically treated brain metastases over the past decade, with up to 60% of brain metastases samples undergoing analysis ...
Maria Nikolaeva, Jacopo Bellomo, Meltem Gönel, Vittorio Stumpo, Victor Egon Staartjes, Flavio Vasella, Kevin Akeret, André Sagerer, Anna Maria Zeitlberger, David Wasilewski, Christopher Krämer, Sven König, Julia Onken, Tareq Juratli, Alexander Köpp, Regina Reimann, Marcus Czabanka, Peter Vajkoczy, Ilker Y. Eyüpoglu, Oliver Bozinov, Michael Weller, Emilie Le Rhun, Luca Regli, Carlo Serra, Marian C. Neidert, Stefanos Voglis   +25 more
wiley   +1 more source

GM-CSF Promotes Superior In Vitro Differentiation of MHC II⁺ CD11c⁺ APCs Compared to L-929 Supernatant in Mouse Bone Marrow Cultures. [PDF]

Int J Mol Sci
Cordeiro G, de Mato FCP, Bonfanti AP, Verinaud L, Rapôso C.   +4 more
europepmc   +1 more source